Unveiling the Impact of Smoking on Allergic Rhinitis: Disease Severity and Efficacy of Subcutaneous Immunotherapy.

Xuan YuanLiyuan LiuBenjian ZhangShaobing XieLai MengWei ZhongJiaxin JiaHua ZhangWeihong JiangZhihai Xie

Published in: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2024)

AR patients across different smoking statuses demonstrated similar baseline disease severity and long-time SCIT efficacy. Active smoking was associated with increased asthma risk, delayed early SCIT efficacy perception, reduced improvement over 3 years, and diminished benefits 2 years after SCIT. Prompt smoking cessation is crucial to mitigate these effects.

Keyphrases

smoking cessation
allergic rhinitis
replacement therapy
end stage renal disease
ejection fraction
chronic obstructive pulmonary disease
peritoneal dialysis
lung function
patient reported outcomes